{"log_id": 5814927564291282000, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 1.9e-05, "average": 0.998161, "min": 0.974102}, "location": {"width": 741, "top": 205, "height": 41, "left": 239}, "words": "虽然文拉法辛不影响健康志愿者的精神活动、认知或复杂行为的执行能力,但是任何精"}, {"probability": {"variance": 5e-05, "average": 0.996819, "min": 0.95941}, "location": {"width": 777, "top": 251, "height": 43, "left": 201}, "words": "神活性药物可能损害判断、思维和运动的执行能力。因此,患者在驾驶车辆和操纵危险的机"}, {"probability": {"variance": 2e-06, "average": 0.998582, "min": 0.996855}, "location": {"width": 102, "top": 312, "height": 24, "left": 203}, "words": "器时应谨慎"}, {"probability": {"variance": 0, "average": 0.742984, "min": 0.742984}, "location": {"width": 27, "top": 327, "height": 27, "left": 1127}, "words": "里"}, {"probability": {"variance": 0.00256, "average": 0.974665, "min": 0.861646}, "location": {"width": 110, "top": 357, "height": 25, "left": 209}, "words": "5.伴随用药"}, {"probability": {"variance": 0, "average": 0.999126, "min": 0.999126}, "location": {"width": 24, "top": 364, "height": 24, "left": 1131}, "words": "件"}, {"probability": {"variance": 5.1e-05, "average": 0.996114, "min": 0.967797}, "location": {"width": 741, "top": 386, "height": 42, "left": 243}, "words": "因为药物间可能有潜在的相互作用,建议患者正在或准备服用任何处方药或非处方药"}, {"probability": {"variance": 0.019005, "average": 0.961579, "min": 0.428396}, "location": {"width": 315, "top": 440, "height": 32, "left": 228}, "words": "包括草药和营养补充剂时通知医生"}, {"probability": {"variance": 0.005082, "average": 0.967645, "min": 0.698726}, "location": {"width": 741, "top": 477, "height": 41, "left": 245}, "words": "应谨慎对待本品合井下列药物引起5-羟色胺综合征的风险,包括曲坦、曲马朵、色氨酸"}, {"probability": {"variance": 0.001819, "average": 0.985516, "min": 0.78649}, "location": {"width": 469, "top": 527, "height": 37, "left": 208}, "words": "补充剂和其他5-羟色胺能的药物(见【药物相互作用】"}, {"probability": {"variance": 0.00907, "average": 0.976016, "min": 0.418181}, "location": {"width": 740, "top": 564, "height": 45, "left": 248}, "words": "应谨慎本品合用非体性抗炎药、阿司匹林、华法令或其他影响血小板凝集的药物,因"}, {"probability": {"variance": 0.009293, "average": 0.973825, "min": 0.47046}, "location": {"width": 645, "top": 613, "height": 39, "left": 213}, "words": "为这些药物和影响5-羟色胺再摄取的精神治疗药物合用与出血风险增加相关"}, {"probability": {"variance": 1e-06, "average": 0.998785, "min": 0.997787}, "location": {"width": 42, "top": 670, "height": 23, "left": 244}, "words": "酒精"}, {"probability": {"variance": 0.000319, "average": 0.994304, "min": 0.908008}, "location": {"width": 736, "top": 700, "height": 40, "left": 255}, "words": "尽管文拉法辛不会增加酒精引起的精神和运动技能的损害,但建议患者服用本品时应"}, {"probability": {"variance": 3.1e-05, "average": 0.993718, "min": 0.988177}, "location": {"width": 40, "top": 762, "height": 21, "left": 215}, "words": "戒酒"}, {"probability": {"variance": 0.002233, "average": 0.979089, "min": 0.863467}, "location": {"width": 117, "top": 802, "height": 31, "left": 214}, "words": "17.过敏反应"}, {"probability": {"variance": 4e-06, "average": 0.998654, "min": 0.991306}, "location": {"width": 530, "top": 838, "height": 37, "left": 259}, "words": "建议当患者出现皮疹、荨麻疹和与过敏有关的表现时告知医生"}, {"probability": {"variance": 0.000782, "average": 0.988692, "min": 0.909616}, "location": {"width": 169, "top": 891, "height": 26, "left": 221}, "words": "8.躯体和精神依赖"}, {"probability": {"variance": 0.005202, "average": 0.981555, "min": 0.550195}, "location": {"width": 736, "top": 917, "height": 41, "left": 256}, "words": "体外研究显示文拉法辛对阿片受体、苯二氮草受体、苯环已哌啶(PCP)受体和NMDA"}, {"probability": {"variance": 0.00054, "average": 0.993025, "min": 0.855806}, "location": {"width": 777, "top": 960, "height": 42, "left": 216}, "words": "受体无亲和力。文拉法辛对啮齿类动物的中枢神经系统无兴奋作用。在对灵长类动物的研究"}, {"probability": {"variance": 0.000333, "average": 0.992562, "min": 0.914956}, "location": {"width": 432, "top": 1005, "height": 36, "left": 219}, "words": "中,文拉法辛无明显兴奋性和镇静方面的滥用倾向"}, {"probability": {"variance": 0.005613, "average": 0.960357, "min": 0.706193}, "location": {"width": 393, "top": 1053, "height": 34, "left": 261}, "words": "文拉法辛停药反应有所报道(见【用法用量】"}, {"probability": {"variance": 0.000694, "average": 0.98831, "min": 0.878729}, "location": {"width": 721, "top": 1091, "height": 40, "left": 257}, "words": "目前尚无文拉法辛是否存在潜在滥用的系统性临床研究。然而对于中枢神经系统(CN"}, {"probability": {"variance": 1e-05, "average": 0.997919, "min": 0.986017}, "location": {"width": 776, "top": 1135, "height": 41, "left": 219}, "words": "活性药物,上市前临床研究不能预示药物上市后有无误用和或滥用的可能。故医生应仔细"}, {"probability": {"variance": 4.3e-05, "average": 0.996311, "min": 0.967873}, "location": {"width": 758, "top": 1179, "height": 42, "left": 221}, "words": "评估和密切随访有药物滥用史的患者,及时发现对文拉法辛的误用或滥用(如:耐受性增强"}, {"probability": {"variance": 0.002844, "average": 0.98051, "min": 0.812004}, "location": {"width": 214, "top": 1234, "height": 31, "left": 222}, "words": "药物的加量和觅药行为)"}, {"probability": {"variance": 2e-06, "average": 0.998634, "min": 0.995392}, "location": {"width": 223, "top": 1278, "height": 31, "left": 229}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 2e-06, "average": 0.998149, "min": 0.996628}, "location": {"width": 43, "top": 1328, "height": 24, "left": 226}, "words": "妊娠"}, {"probability": {"variance": 6.9e-05, "average": 0.996327, "min": 0.967034}, "location": {"width": 729, "top": 1358, "height": 39, "left": 263}, "words": "孕妇使用文拉法辛缓释胶囊的安全性尚未建立。如果在治疗期间发生怀孕或计划怀孕"}, {"probability": {"variance": 8.2e-05, "average": 0.996386, "min": 0.944901}, "location": {"width": 777, "top": 1402, "height": 42, "left": 223}, "words": "应告知医师。仅当使用本品获益大于可能的风险时方可使用。如果需要一直用药至分娩或分"}, {"probability": {"variance": 0.000135, "average": 0.994749, "min": 0.946561}, "location": {"width": 775, "top": 1448, "height": 39, "left": 225}, "words": "娩前,应考虑新生儿出现的停药反应。某些第7至第9孕月以后暴露于文拉法辛的新生儿已发"}, {"probability": {"variance": 0.004505, "average": 0.980462, "min": 0.670605}, "location": {"width": 725, "top": 1491, "height": 39, "left": 227}, "words": "生需要鼻饲、呼吸支持或延长住院的并发症。这些并发症会在新生儿出生后立即发生"}], "language": 3}